- Home
- AKRO vs BMA Comparison
AKRO vs BMA Comparison
Compare AKRO & BMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- BMA
- Stock Information
- Founded
- AKRO 2017
- BMA 1966
- Country
- AKRO United States
- BMA Argentina
- Employees
- AKRO N/A
- BMA N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- BMA Commercial Banks
- Sector
- AKRO Health Care
- BMA Finance
- Exchange
- AKRO Nasdaq
- BMA Nasdaq
- Market Cap
- AKRO 3.7B
- BMA 4.2B
- IPO Year
- AKRO 2019
- BMA 2006
- Fundamental
- Price
- AKRO $54.00
- BMA $85.41
- Analyst Decision
- AKRO Buy
- BMA Buy
- Analyst Count
- AKRO 10
- BMA 6
- Target Price
- AKRO $73.56
- BMA $81.70
- AVG Volume (30 Days)
- AKRO 4.1M
- BMA 932.3K
- Earning Date
- AKRO 11-07-2025
- BMA 11-26-2025
- Dividend Yield
- AKRO N/A
- BMA 1.72%
- EPS Growth
- AKRO N/A
- BMA N/A
- EPS
- AKRO N/A
- BMA 0.50
- Revenue
- AKRO N/A
- BMA $2,573,406,817.00
- Revenue This Year
- AKRO N/A
- BMA N/A
- Revenue Next Year
- AKRO N/A
- BMA $3.01
- P/E Ratio
- AKRO N/A
- BMA $16.59
- Revenue Growth
- AKRO N/A
- BMA N/A
- 52 Week Low
- AKRO $21.34
- BMA $38.30
- 52 Week High
- AKRO $58.40
- BMA $118.42
- Technical
- Relative Strength Index (RSI)
- AKRO 68.71
- BMA 82.36
- Support Level
- AKRO $53.40
- BMA $51.35
- Resistance Level
- AKRO $54.05
- BMA $85.19
- Average True Range (ATR)
- AKRO 0.26
- BMA 4.37
- MACD
- AKRO -0.03
- BMA 3.86
- Stochastic Oscillator
- AKRO 72.46
- BMA 92.98
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About BMA Banco Macro S.A. ADR (representing Ten Class B)
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.